Psychedelic medicine to be worth US$5 billion by 2028
Tomorrow, Thursday, 17 November, industry leaders will meet in London for Emerging Innovations in Psychedelic Healthcare, to evaluate milestones in the commercialisation of psychedelic medicine.
The invite-only event, taking place at Sea Containers in South Bank, coincides with the release of The Psychedelics as Medicine Report: Fourth Edition.
The industry’s leading data and insights publication features contributions from researchers, regulators, lawyers and politicians, with thought leaders analysing the sector’s socioeconomic potential.
REGISTER YOUR INTEREST FOR TOMORROW'S EVENT